Plegee Monday, 09/03/18 08:50:40 AM Re: None Post # of 8026 Bottom looks to be in from a TA perspective, good risk/reward starting point. Fundamentally, news and progress will eventually support/mitigate current share price. Cohart 5 results released last week or so is a good start and recent presentation at 8/29 biotech conference helps as well. Filling the TA gap is also very enticing. In with a new position.